Next |
home / stock / axgt / axgt message board
Subject | By | Source | When |
---|---|---|---|
AXOVANT ANNOUNCES GLOBAL LICENSING AGREEMENT FOR AXO-AAV-OPMD PROGRAM | georgejjl | investorshub | 06/06/2019 1:32:55 AM |
I cannot believe this company is still scamming | BostonSportsNut | investorshub | 05/23/2019 12:20:51 AM |
sitting on a big day here | whosjohngalt | investorshub | 03/11/2019 11:52:08 AM |
closing in on 52 week high | whosjohngalt | investorshub | 03/07/2019 6:34:47 PM |
good volume, good move today. eom | whosjohngalt | investorshub | 03/04/2019 9:39:53 PM |
rolling, settle down everyone | whosjohngalt | investorshub | 02/27/2019 7:16:25 PM |
and looking good | whosjohngalt | investorshub | 02/23/2019 8:13:55 AM |
Correction AXGT | Phoenix300 | investorshub | 02/15/2019 7:12:55 PM |
Board needs to be switched over to AGXT board | Phoenix300 | investorshub | 02/15/2019 7:10:49 PM |
well other then the ticker change | whosjohngalt | investorshub | 02/14/2019 5:50:51 PM |
AXGT | Phoenix300 | investorshub | 02/14/2019 2:55:56 PM |
Axovant Announces Formation of Arvelle Therapeutics and Strategic | Phoenix300 | investorshub | 02/14/2019 2:42:20 PM |
pretty significant pr released this morning. eom | whosjohngalt | investorshub | 02/14/2019 1:50:37 PM |
* * $AXON Video Chart 02-06-2019 * * | ClayTrader | investorshub | 02/06/2019 10:26:12 PM |
looking good | whosjohngalt | investorshub | 02/06/2019 7:45:44 PM |
News: $AXON Health Stocks Benefitting the Most from Rally | whytestocks | investorshub | 01/22/2019 2:36:27 PM |
I will set up to short this . | FastBuxJones | investorshub | 12/19/2018 12:31:32 PM |
Traded this twice today! Thanks for the Quick | ALL-IN888 | investorshub | 12/17/2018 4:56:16 PM |
When are the earnings | hwpbnj | investorshub | 11/02/2018 8:49:21 PM |
Sheila Roy is a true pioneer for ProSavin | georgejjl | investorshub | 10/30/2018 6:10:18 AM |
News, Short Squeeze, Breakout and More Instantly...
Axovant Gene Therapies Ltd. Company Name:
AXGT Stock Symbol:
NYSE Market:
On-track to report t opline r esults from low-dose cohort by end of 2020 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company focused on developing gene therapies to ra...
A pioneering researcher , Dr. Gao has made foundational contributions to the discovery of novel AAV vectors for gene therapy Dr. Gao recently served as President of the American Society for Gene and Cell Therapy (ASGCT) and has been ranked as one of...
Rebranding to Sio Gene Therapies to reflect an independent company with a scientific strategy focused on disease-modifying and curative genetic medicines Company’s common stock will trade on the NASDAQ under new ticker “SIOX” effective November 13, 2020 ...